Literature DB >> 8070153

Fatal intracerebral hemorrhage following thrombolytic therapy of embolic myocardial infarction in unsuspected infective endocarditis.

T G Di Salvo1, S B Tatter, P T O'Gara, G P Nielsen, R W DeSanctis.   

Abstract

Cerebral hemorrhage occurs in 0.2% of patients under the age of 60 years treated with thrombolytic therapy for acute myocardial infarction. A case of fatal cerebral hemorrhage following TPA therapy for myocardial infarction due to probable coronary artery embolism during unsuspected native valve infective endocarditis is reported.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8070153     DOI: 10.1002/clc.4960170613

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  5 in total

1.  Uncertainties in managing myocardial infarction associated with infective endocarditis.

Authors:  Louise Overend; Edward Rose
Journal:  Exp Clin Cardiol       Date:  2012-09

2.  Intracranial hemorrhage following thrombolytic use for stroke caused by infective endocarditis.

Authors:  Parita Bhuva; Sheng-Han Kuo; J Claude Hemphill; George A Lopez
Journal:  Neurocrit Care       Date:  2009-08-18       Impact factor: 3.210

3.  Successful intravenous thrombolysis in ischemic stroke caused by infective endocarditis.

Authors:  Mithri Junna; Chang-Ching D Lin; Raul E Espinosa; Alejandro A Rabinstein
Journal:  Neurocrit Care       Date:  2007       Impact factor: 3.210

4.  Myocardial infarction associated with infective endocarditis: a case series.

Authors:  Sofía Calero-Núñez; Vicente Ferrer Bleda; Miguel Corbí-Pascual; Juan Gabriel Córdoba-Soriano; Raquel Fuentes-Manso; Antonia Tercero-Martínez; Jesús Jiménez-Mazuecos; María Isabel Barrionuevo Sánchez
Journal:  Eur Heart J Case Rep       Date:  2018-03-23

5.  ST segment elevation caused by ostial right coronary artery obstruction in infective endocarditis: a case report.

Authors:  Alexander Bolton; Georges Hajj; Laila Payvandi; Christopher Komanapalli
Journal:  BMC Cardiovasc Disord       Date:  2020-09-11       Impact factor: 2.298

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.